Insurance Type Influences Access to Biologics and Healthcare Utilization in Pediatric Crohn's Disease.

ABSTRACT:

Background

The objective of this study is to determine if there is an association between insurance status and access to biologics among children with Crohn's disease (CD). Additionally, we seek to determine differences in healthcare utilization between these groups, utilizing a national sample of children with CD.

Methods

Children aged 8-18 with a diagnosis of CD were identified from 2012-2016 Truven Health MarketScan (IBM Watson Health). Patients were classified into Public/Medicaid or as Commercial/Privately Insured. Descriptive statistics were compared between groups and sensitivity analysis performed using inverse probability of treatment weighting. Adjusted differences in healthcare utilization were estimated by multiple linear regression models.

Results

We iden

SUBMITTER: Quiros JA 

PROVIDER: S-EPMC9802312 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature